ZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative Components
23 July 2024 - 10:00PM
ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the
dental market, today announced the U.S. launch of its GenTek®
Genuine Restorative Components product portfolio. The launch
expands ZimVie’s portfolio of end-to-end prosthetic offerings and
follows the recent receipt of FDA 510(k) clearance. ZimVie first
launched the GenTek portfolio in Europe in 2019 and has seen
tremendous success in that market to date.
The introduction of GenTek to the U.S. market brings a broad
offering of differentiated restorative components to the ZimVie
product family. The GenTek restorative portfolio is comprised of
Ti-Bases, pre-milled abutment blanks, screws, instruments, and
ancillary products to support digitally driven CAD/CAM
restorations. Manufactured and designed to mate with ZimVie implant
systems, the genuine connection* ensures a perfect fit and tight
seal to support long-term aesthetic and functional
restorations.
“We’re excited to expand our product portfolio with the
introduction of GenTek premium prosthetic components, enabling
digital workflows and patient-specific restorations for U.S.
customers,” said Indraneel Kanaglekar, SVP, Chief Commercial
Officer. “We have received excellent feedback and strong demand for
GenTek in the European market, and we are optimistic that this
product suite will be well received here in the U.S. – the largest
market we serve.”
A Media Snippet accompanying this announcement is available by
clicking on this link.
About GenTek®Genuine
connection components are designed and manufactured to minimize the
micro-gaps and micro-movements for a robust and stable interface
between the implant and abutment. GenTek CEREC® compatible (Sirona
inCoris Meso Block) and angulated screw channel Ti-Bases,
pre-milled abutment blanks, and scan bodies are part of a complete
and open digital workflow. Products are available for ZimVie’s
TSX®/ TSV®/Trabecular
Metal®, T3®
PRO/Certain®, and Eztetic® Dental
Implant Systems.
For more information on our GenTek portfolio, visit
https://www.zimvie.com/en/dental/restorative-products/gentek-genuine-restorative-components-na.html.
For more information on ZimVie Dental implants, suite of
connected solutions, and continuing education, please visit
https://www.zimvie.com.
*GenTek is manufactured by Zfx GmbH, a subsidiary of ZimVie.
About ZimVieZimVie is a global life sciences
leader in the dental market that develops, manufactures, and
delivers a comprehensive portfolio of products and solutions
designed to support dental tooth replacement and restoration
procedures. From its headquarters in Palm Beach Gardens, Florida,
and additional facilities around the globe, ZimVie works to improve
smiles, function, and confidence in daily life by offering
comprehensive tooth replacement solutions, including trusted dental
implants, biomaterials, and digital workflow solutions. As a
worldwide leader in this space, ZimVie is committed to advancing
clinical science and technology foundational to restoring daily
life. For more information about ZimVie, please visit us at
www.ZimVie.com. Follow @ZimVie on Twitter, Facebook, LinkedIn, or
Instagram.
Cautionary Note Regarding Forward-Looking
StatementsThis press release contains forward-looking
statements within the meaning of the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements include, but are not limited to, statements concerning
ZimVie’s expectations, plans, prospects, and product and service
offerings, including new product launches and potential clinical
successes. Such statements are based upon the current beliefs,
expectations, and assumptions of management and are subject to
significant risks, uncertainties, and changes in circumstances that
could cause actual outcomes and results to differ materially from
the forward-looking statements. For a list and description of some
of such risks and uncertainties, see ZimVie’s periodic reports
filed with the U.S. Securities and Exchange Commission (SEC). These
factors should not be construed as exhaustive and should be read in
conjunction with the other cautionary statements that are included
in ZimVie’s filings with the SEC. Forward-looking statements speak
only as of the date they are made, and ZimVie disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events,
or otherwise. Readers of this press release are cautioned not to
rely on these forward-looking statements, since there can be no
assurance that these forward-looking statements will prove to be
accurate. This cautionary note is applicable to all forward-looking
statements contained in this press release.
Media Contact
Information:ZimVieAllison Johnson •
Allison.Johnson@ZimVie.com(774) 266-8046
ZimVieGrace Flowers •
Grace.Flowers@ZimVie.com(561) 319-6130
Investor Contact Information:Gilmartin
Group LLCMarissa Bych • Marissa@gilmartinir.com
ZimVie (NASDAQ:ZIMV)
Historical Stock Chart
From Nov 2024 to Dec 2024
ZimVie (NASDAQ:ZIMV)
Historical Stock Chart
From Dec 2023 to Dec 2024